NSE: JAGSNPHARM
JAGSONPAL PHARMACEUTICALS
Price history
+11.10% over 3M
Performance
52-week range
Position in day range
JAGSNPHARM stock DNA
Signals computed live from NSE price history — trend, momentum, volatility and participation in one view.
Trend
Uptrend
50-DMA ₹232.56
RSI (14)
37
Neutral momentum
Volatility (ATR)
3.40%
Moderate
Close streak
6d down
Volume vs 20d avg
0.24x
From 52W high
-10.99%
Up from 52W low
+51.90%
Green days (20)
9/20
Monthly seasonality
Average monthly move for JAGSNPHARM across the available price history.
Key statistics
Open
235.39
Day high
239.17
Day low
233.1
Prev close
235.44
Volume
24,747
Avg vol (20d)
1.04 L
52W high
264.5
52W low
155
JAGSNPHARM quarterly results
All JAGSNPHARM results →Next results date
Awaiting intimation
Last results date
—
Reports published
Coverage coming soon
Revenue
₹82.23 cr
+8.8% YoY
Net profit
₹13.19 cr
+22.2% YoY
Operating profit
₹15.1 cr
+27.3% YoY
EPS
₹2.00
+25.0% YoY
| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|---|---|---|---|---|---|---|---|
| Q1 FY272026-06-30 | ₹82.23 cr | ₹15.1 cr | ₹13.19 cr | 18.4% | 16.0% | ₹2.00 | +22.2% | +50.5% |
| Q4 FY262026-03-31 | ₹64.2 cr | ₹8.84 cr | ₹8.76 cr | 13.8% | 13.6% | ₹1.25 | — | -20.0% |
| Q3 FY262025-12-31 | ₹72.95 cr | ₹13.88 cr | ₹10.95 cr | 19.0% | 15.0% | ₹1.67 | — | -12.9% |
| Q2 FY262025-09-30 | ₹74.47 cr | ₹14.05 cr | ₹12.57 cr | 18.9% | 16.9% | ₹1.88 | — | +16.5% |
| Q1 FY262025-06-30 | ₹75.61 cr | ₹11.86 cr | ₹10.8 cr | 15.7% | 14.3% | ₹1.60 | — | — |
| TTM (last 4 quarters) | ₹294 cr | ₹51.87 cr | ₹45.48 cr | 17.7% | 15.5% | ₹6.80 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
Latest coverage
No stories tagged with JAGSNPHARM yet — see the latest from the markets desk below.
Latest market news
Solar Industries (I) Share Price Trades Flat at ₹22,290.00: What Is Driving SOLARINDS Today, and the Levels That Matter
Solar Industries (I) (SOLARINDS) trades at ₹22,290.00, -80.00 (-0.36%) as the in-focus story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.
Jubilant Pharmova Share Price Trades Flat at ₹1,025.20 Today — Volumes, 52-Week Range and What to Watch Next
Jubilant Pharmova (JUBLPHARMA) trades at ₹1,025.20, -0.45 (-0.04%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Coforge Share Price Opens Gap-Down at ₹1,807.30: What Is Driving COFORGE Today, and the Levels That Matter
Coforge (COFORGE) trades at ₹1,846.50, +13.40 (+0.73%) as the in-focus story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.
Aavas Financiers Share Price Edges Lower to ₹1,271.50 Today — Volumes, 52-Week Range and What to Watch Next
Aavas Financiers (AAVAS) trades at ₹1,271.50, -14.60 (-1.15%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
Morning Market Buzz, 12 September 2026: IPOs Tops the Coverage Ahead of Policy And Macro Data and Banks And NBFCs
The most-covered market themes in the morning session on 12 September 2026 — IPOs, policy and macro data, banks and NBFCs — with our live numbers for each and links to the publishers running the story.
Raymond Share Price Hits 52-Week High, Up 14.85%: What Is Driving RAYMOND Today, and the Levels That Matter
Raymond (RAYMOND) trades at ₹1,002.80, +148.95 (+14.85%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Price and history data from NSE via Upstox. For information only, not investment advice.